PDCD1 and cancer: Among cancer immunotherapy, immune checkpoint blockade (ICB), which targets cytotoxic T lymphocyte antigen 4 (CTLA4) or the programmed cell death 1 (PD1)-ligand 1 (PD­ L1) axis has been approved for treating many different cancers1.